AstraZeneca PLC vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.5
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
AZN
High-quality business with 23% return on equity and 17% profit margins.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $223.79 (+21.1%)
10 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
AZN
JNJ
27.9×
Trailing P/E
26.3×
23.7×
Forward P/E
17.9×
17.2%
Profit Margin
21.8%
81.5%
Gross Margin
68.0%
23.5%
ROE
26.4%
12.5%
Revenue Growth
9.9%
5.3%
Earnings Growth
-52.9%
0.28
Beta
0.33
—
Price / Book
—
$286.4B
Market Cap
$546.9B
$132 – $213
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →